Final results of neoadjuvant trial of bevacizumab (B) and trastuzumab (T) in combination with weekly paclitaxel (P) as neoadjuvant treatment in HER2-positive breast cancer: A phase II trial (AVANTHER)

被引：0
|
作者：
Fernandez, M.
Calvo, I.
Martinez, N.
Herrero, M.
Quijano, Y.
Duran, H.
Garcia-Aranda, M.
Suarez, A.
-Rios, F. Lopez
Perez, D.
Perea, S.
Hidalgo, M.
Garcia-Estevez, L.
机构：
[1] Ctr Integral Oncol Clara Campal, Madrid, Spain
[2] Hosp Ramon & Cajal, E-28034 Madrid, Spain
[3] Hosp Costa del Sol, Marbella, Spain
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/0008-5472.SABCS12-P1-14-10
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-14-10
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase II Study of Neoadjuvant Weekly nab-Paclitaxel and Carboplatin, With Bevacizumab and Trastuzumab, As Treatment For Women With Locally Advanced HER2+ Breast Cancer
    Yardley, Denise A.
    Raefsky, Eric
    Castillo, Raul
    Lahiry, Anup
    LoCicero, Richard
    Thompson, Dana
    Shastry, Mythili
    Burris, Howard A., III
    Hainsworth, John D.
    CLINICAL BREAST CANCER, 2011, 11 (05) : 297 - 305
  • [32] Final results of a phase 2 trial using a novel, non-anthracycline neoadjuvant chemotherapy regimen in Her2-positive breast cancer
    O'Regan, Ruth M.
    Gabram, Sheryl
    Styblo, Toncred
    Rizzo, Monica
    Wood, William
    Srinivasiah, Jayanthi
    Jonas, William
    Schnell, Fred
    Adams, Amy
    Nahta, Rita
    Zelnak, Amelia
    CANCER RESEARCH, 2012, 72
  • [33] Neoadjuvant treatment for HER2-positive breast cancer
    Takada, Masahiro
    Toi, Masakazu
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (03)
  • [34] Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer
    Rocca, Andrea
    Cortesi, Pietro
    Cortesi, Laura
    Gianni, Lorenzo
    Matteucci, Federica
    Fantini, Lorenzo
    Maestri, Antonio
    Giunchi, Donata Casadei
    Cavanna, Luigi
    Ciani, Rosa
    Falcini, Fabio
    Bagni, Antonella
    Meldoli, Elena
    Dall'Agata, Monia
    Volpi, Roberta
    Andreis, Daniele
    Nanni, Oriana
    Curcio, Annalisa
    Lucchi, Leonardo
    Amadori, Dino
    Fedeli, Anna
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [35] Phase II open clinical trial to evaluate efficacy and safety of neoadjuvant trastuzumab in HER2-positive locally advanced breast cancer (LABC)
    Arce-Salinas, C. H.
    Lara, F. U.
    Leon, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [36] Neoadjuvant ixabepilone/carboplatin/trastuzumab in HER2-positive locally advanced breast cancer: A Sarah Cannon Research Institute phase II trial
    Zubkus, J. D.
    Daniel, D. B.
    Eakle, J. F.
    Bechhold, R. G.
    Shastry, M.
    Tucker, P. S.
    Burris, H. A.
    Hainsworth, J. D.
    Yardley, D. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [37] A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancer
    Lin, N. U.
    Seah, D. S.
    Gelman, R.
    Desantis, S.
    Mayer, E. L.
    Isakoff, S.
    DiPiro, P.
    Krop, I. E.
    Come, S. E.
    Weckstein, D.
    Winer, E. P.
    Burstein, H. J.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 139 (02) : 403 - 410
  • [38] De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab in HER2-positive early breast cancer (HELEN-006):a randomized,phase 3 trial
    Liu, Zhenzhen
    Chen, Xiuchun
    Qiao, Jianghua
    Jiao Dechuang
    Wang, Chengzheng
    Sun, Xianfu
    Lu, Zhenduo
    Li, Lianfang
    Zhang, Chongjian
    Yan, Min
    Wei, Ya
    Bo, Chen
    Feng, Yueqing
    Deng, Miao
    Ma, Mingde
    CANCER RESEARCH, 2024, 84 (09)
  • [39] A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancer
    N. U. Lin
    D. S. Seah
    R. Gelman
    S. Desantis
    E. L. Mayer
    S. Isakoff
    P. DiPiro
    I. E. Krop
    S. E. Come
    D. Weckstein
    E. P. Winer
    H. J. Burstein
    Breast Cancer Research and Treatment, 2013, 139 : 403 - 410
  • [40] A Phase II Preoperative Trial of Concurrent Trastuzumab and Paclitaxel without Anthracycline in HER2-Positive Operable Breast Cancer
    Sato, T.
    Hayashida, T.
    Takahashi, M.
    Sakata, M.
    Jinno, H.
    Hirose, S.
    Mukai, M.
    Kitagawa, Y.
    CANCER RESEARCH, 2010, 70
12345